Keros Therapeutics, Inc. (KROS) NASDAQ
$52.51 (1.17) (-2.18%)
Market Cap: $1.97B
As of 09/06/24 04:00 PM EDT. Market closed.
Keros Therapeutics, Inc. (KROS)
NASDAQ
$52.51
(1.17) (-2.18%)
Market Cap: $1.97B
As of 09/06/24 04:00 PM EDT. Market closed.
Add to Portfolio
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Jasbir S. Seehra Ph.D.
Full Time Employees
149
CEO Compensation (Base)
$649,135
CEO Compensation (Total)
$8.93M
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Jasbir S. Seehra Ph.D.
Full Time Employees
149
CEO Compensation (Base)
$649,135
CEO Compensation (Total)
$8.93M
URL
Address
99 Hayden Avenue, MA, Lexington, 02421.
PRICE CHART FOR KEROS THERAPEUTICS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$53.83
Previous Close
$53.68
Days Range
$51.84 - $54.67
52 week range
$27.02 - $73
Volume
390,322
Avg. Volume (30 days)
369,932
Market Cap
$1.97B
Dividend Yield
-
P/E
(10.24)
Shares Outstanding
37,522,100
Open
$53.83
Previous Close
$53.68
Days Range
$51.84 - $54.67
52 week range
$27.02 - $73
Volume
390,322
Avg. Volume (30 days)
369,932
Market Cap
$1.97B
Dividend Yield
-
P/E
(10.24)
Shares Outstanding
37,522,100
FINANCIAL STATEMENTS FOR KEROS THERAPEUTICS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR KEROS THERAPEUTICS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| GORDON CARL L | Director | Aug 13, 2024 | Sale | $44.01 | 250,000 | 11,002,500 | 899,212 | Aug 15, 2024, 05:06 PM |
| ORBIMED ADVISORS LLC | Director | Aug 13, 2024 | Sale | $44.01 | 250,000 | 11,002,500 | 899,212 | Aug 15, 2024, 05:01 PM |
| Regnante Keith | Chief Financial Officer | Nov 04, 2023 | Option Exercise | $16.00 | 40,000 | 640,000 | 40,000 | Jan 08, 2024, 04:43 PM |
| Regnante Keith | Chief Financial Officer | Nov 04, 2023 | Sale | $45.29 | 40,000 | 1,811,600 | 0 | Jan 08, 2024, 04:43 PM |
| Regnante Keith | Chief Financial Officer | Jun 09, 2023 | Option Exercise | $16.00 | 20,000 | 320,000 | 20,000 | Jun 12, 2023, 04:13 PM |
| Regnante Keith | Chief Financial Officer | Jun 08, 2023 | Option Exercise | $16.00 | 20,000 | 320,000 | 20,000 | Jun 12, 2023, 04:13 PM |
| Regnante Keith | Chief Financial Officer | Jun 08, 2023 | Sale | $47.79 | 20,000 | 955,872 | 2,699 | Jun 12, 2023, 04:13 PM |
| Regnante Keith | Chief Financial Officer | Jun 09, 2023 | Sale | $45.42 | 20,000 | 908,367 | 4,007 | Jun 12, 2023, 04:13 PM |
| Seehra Jasbir | Chief Executive Officer | Apr 08, 2023 | Option Exercise | $0.48 | 4,000 | 1,920 | 252,856 | Apr 11, 2023, 04:05 PM |
| Knowles Julius | Director | Apr 13, 2020 | Buy | $20.98 | 1,191 | 24,987 | 1,191 | Jan 20, 2023, 04:32 PM |
| Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Nov 29, 2022 | Option Exercise | $0.00 | 7,176 | 1 | 2,284,612 | Nov 30, 2022, 04:42 PM |
| Nussbaum Ran | Director | Nov 29, 2022 | Option Exercise | $0.00 | 7,176 | 1 | 2,284,612 | Nov 30, 2022, 04:40 PM |
| Kariv Tomer | Director | Nov 29, 2022 | Option Exercise | $0.00 | 7,176 | 1 | 2,284,612 | Nov 30, 2022, 04:38 PM |
| Lachey Jennifer | Chief Scientific Officer | Jul 15, 2022 | Option Exercise | $0.30 | 46,034 | 13,810 | 141,134 | Jul 19, 2022, 04:40 PM |
| Lachey Jennifer | Chief Scientific Officer | Jul 15, 2022 | Sale | $30.00 | 46,034 | 1,381,020 | 95,100 | Jul 19, 2022, 04:40 PM |
| Lachey Jennifer | Chief Scientific Officer | Jul 13, 2022 | Option Exercise | $0.30 | 1,916 | 575 | 93,184 | Jul 15, 2022, 04:40 PM |
| Lachey Jennifer | Chief Scientific Officer | Jul 13, 2022 | Sale | $30.00 | 1,916 | 57,480 | 95,100 | Jul 15, 2022, 04:40 PM |
| Lachey Jennifer | Chief Scientific Officer | Jun 14, 2022 | Option Exercise | $0.30 | 9,400 | 2,820 | 95,100 | Jun 14, 2022, 06:57 PM |
| Seehra Jasbir | Chief Executive Officer | Jun 09, 2022 | Option Exercise | $0.30 | 5,000 | 1,500 | 248,856 | Jun 10, 2022, 04:12 PM |
| Lachey Jennifer | Chief Scientific Officer | May 11, 2022 | Option Exercise | $0.30 | 5,300 | 1,590 | 91,000 | May 13, 2022, 04:37 PM |
| Lachey Jennifer | Chief Scientific Officer | May 11, 2022 | Sale | $41.90 | 5,300 | 222,050 | 87,602 | May 13, 2022, 04:37 PM |
| Lachey Jennifer | Chief Scientific Officer | Apr 11, 2022 | Option Exercise | $0.30 | 5,300 | 1,590 | 91,000 | Apr 13, 2022, 04:36 PM |
| Lachey Jennifer | Chief Scientific Officer | Apr 11, 2022 | Sale | $62.77 | 5,300 | 332,705 | 89,583 | Apr 13, 2022, 04:36 PM |
| Rovaldi Christopher | Chief Operating Officer | Apr 06, 2022 | Option Exercise | $16.00 | 1,728 | 27,648 | 1,728 | Apr 08, 2022, 04:21 PM |
| Rovaldi Christopher | Chief Operating Officer | Apr 06, 2022 | Sale | $65.00 | 1,728 | 112,320 | 0 | Apr 08, 2022, 04:21 PM |
| Lachey Jennifer | Chief Scientific Officer | Apr 04, 2022 | Option Exercise | $0.30 | 7,950 | 2,385 | 93,650 | Apr 06, 2022, 04:49 PM |
| Lachey Jennifer | Chief Scientific Officer | Apr 04, 2022 | Sale | $60.00 | 7,950 | 477,000 | 85,700 | Apr 06, 2022, 04:49 PM |
| Rovaldi Christopher | Chief Operating Officer | Apr 01, 2022 | Option Exercise | $16.00 | 864 | 13,824 | 864 | Apr 05, 2022, 04:31 PM |
| Rovaldi Christopher | Chief Operating Officer | Apr 01, 2022 | Sale | $57.49 | 864 | 49,675 | 862 | Apr 05, 2022, 04:31 PM |
| Lachey Jennifer | Chief Scientific Officer | Mar 11, 2022 | Option Exercise | $0.30 | 2,650 | 795 | 88,350 | Mar 15, 2022, 04:37 PM |
| Lachey Jennifer | Chief Scientific Officer | Mar 11, 2022 | Sale | $53.38 | 2,650 | 141,449 | 87,288 | Mar 15, 2022, 04:37 PM |
| Lachey Jennifer | Chief Scientific Officer | Feb 11, 2022 | Option Exercise | $0.30 | 2,650 | 795 | 88,350 | Feb 15, 2022, 04:26 PM |
| Lachey Jennifer | Chief Scientific Officer | Feb 11, 2022 | Sale | $52.06 | 2,650 | 137,965 | 87,277 | Feb 15, 2022, 04:26 PM |
| Lachey Jennifer | Chief Scientific Officer | Jan 11, 2022 | Option Exercise | $0.30 | 2,650 | 795 | 88,350 | Jan 13, 2022, 04:39 PM |
| Lachey Jennifer | Chief Scientific Officer | Jan 11, 2022 | Sale | $53.75 | 2,650 | 142,447 | 88,030 | Jan 13, 2022, 04:39 PM |
| Lachey Jennifer | Chief Scientific Officer | Jan 05, 2022 | Option Exercise | $0.30 | 2,650 | 795 | 88,350 | Jan 07, 2022, 04:35 PM |
| Lachey Jennifer | Chief Scientific Officer | Jan 05, 2022 | Sale | $60.00 | 2,650 | 159,000 | 85,700 | Jan 07, 2022, 04:35 PM |
| Knowles Julius | Director | Jan 05, 2022 | Sale | $58.25 | 4,034 | 234,991 | 343,597 | Jan 05, 2022, 07:14 PM |
| Knowles Julius | Director | Jan 04, 2022 | Sale | $57.55 | 20,062 | 1,154,667 | 355,365 | Jan 05, 2022, 07:14 PM |
| Knowles Julius | Director | Jan 03, 2022 | Sale | $58.01 | 23,555 | 1,366,458 | 366,738 | Jan 05, 2022, 07:14 PM |
| Lachey Jennifer | Chief Scientific Officer | Dec 13, 2021 | Option Exercise | $0.30 | 1,915 | 575 | 87,615 | Dec 15, 2021, 04:48 PM |
| Lachey Jennifer | Chief Scientific Officer | Dec 15, 2021 | Option Exercise | $0.30 | 735 | 221 | 86,435 | Dec 15, 2021, 04:48 PM |
| Lachey Jennifer | Chief Scientific Officer | Dec 15, 2021 | Sale | $50.00 | 735 | 36,750 | 85,700 | Dec 15, 2021, 04:48 PM |
| Lachey Jennifer | Chief Scientific Officer | Dec 13, 2021 | Sale | $50.55 | 1,915 | 96,808 | 86,097 | Dec 15, 2021, 04:48 PM |
| Knowles Julius | Director | Dec 02, 2021 | Sale | $53.57 | 25,338 | 1,357,381 | 385,673 | Dec 03, 2021, 05:05 PM |
| Knowles Julius | Director | Dec 01, 2021 | Sale | $54.68 | 22,313 | 1,219,994 | 395,014 | Dec 03, 2021, 05:05 PM |
| Lachey Jennifer | Chief Scientific Officer | Nov 10, 2021 | Option Exercise | $0.30 | 15,900 | 4,770 | 101,600 | Nov 12, 2021, 04:40 PM |
| Lachey Jennifer | Chief Scientific Officer | Nov 11, 2021 | Option Exercise | $0.30 | 5,300 | 1,590 | 91,000 | Nov 12, 2021, 04:40 PM |
| Lachey Jennifer | Chief Scientific Officer | Nov 10, 2021 | Sale | $60.00 | 15,900 | 954,000 | 85,700 | Nov 12, 2021, 04:40 PM |
| Lachey Jennifer | Chief Scientific Officer | Nov 11, 2021 | Sale | $59.63 | 5,300 | 316,058 | 90,261 | Nov 12, 2021, 04:40 PM |
| Lachey Jennifer | Chief Scientific Officer | Nov 04, 2021 | Option Exercise | $0.30 | 10,600 | 3,180 | 96,300 | Nov 05, 2021, 05:06 PM |
| Lachey Jennifer | Chief Scientific Officer | Nov 04, 2021 | Sale | $50.00 | 10,600 | 530,000 | 85,700 | Nov 05, 2021, 05:06 PM |
| Knowles Julius | Director | Nov 03, 2021 | Sale | $41.95 | 15,967 | 669,780 | 402,854 | Nov 03, 2021, 07:04 PM |
| Knowles Julius | Director | Nov 02, 2021 | Sale | $42.40 | 7,881 | 334,149 | 410,439 | Nov 03, 2021, 07:04 PM |
| Knowles Julius | Director | Nov 01, 2021 | Sale | $42.15 | 23,803 | 1,003,201 | 421,041 | Nov 03, 2021, 07:04 PM |
| Knowles Julius | Director | Oct 20, 2021 | Sale | $38.24 | 4,082 | 156,095 | 430,340 | Oct 21, 2021, 04:29 PM |
| Knowles Julius | Director | Oct 19, 2021 | Sale | $38.16 | 4,516 | 172,346 | 431,273 | Oct 21, 2021, 04:29 PM |
| Knowles Julius | Director | Oct 15, 2021 | Sale | $39.16 | 8,198 | 321,052 | 443,577 | Oct 18, 2021, 08:35 PM |
| Knowles Julius | Director | Oct 14, 2021 | Sale | $40.13 | 4,383 | 175,890 | 446,608 | Oct 18, 2021, 08:35 PM |
| Knowles Julius | Director | Oct 18, 2021 | Sale | $37.70 | 13,786 | 519,711 | 433,394 | Oct 18, 2021, 08:35 PM |
| Knowles Julius | Director | Oct 05, 2021 | Sale | $40.03 | 2,617 | 104,759 | 449,261 | Oct 05, 2021, 08:47 PM |
| Knowles Julius | Director | Oct 04, 2021 | Sale | $40.06 | 3,746 | 150,065 | 450,845 | Oct 05, 2021, 08:47 PM |
| Knowles Julius | Director | Oct 01, 2021 | Sale | $40.16 | 6,323 | 253,932 | 453,112 | Oct 05, 2021, 08:47 PM |
| Knowles Julius | Director | Sep 27, 2021 | Sale | $41.17 | 95,302 | 3,924,003 | 487,249 | Sep 29, 2021, 04:39 PM |
| Lachey Jennifer | Chief Scientific Officer | Aug 17, 2021 | Option Exercise | $0.30 | 1,293 | 388 | 85,700 | Aug 18, 2021, 05:21 PM |
| Knowles Julius | Director | Jul 02, 2021 | Sale | $41.34 | 23,818 | 984,565 | 520,411 | Jul 06, 2021, 06:02 PM |
| Knowles Julius | Director | Jul 01, 2021 | Sale | $41.28 | 23,834 | 983,787 | 530,196 | Jul 06, 2021, 06:02 PM |
| Lachey Jennifer | Chief Scientific Officer | Jun 24, 2021 | Option Exercise | $0.30 | 6,500 | 1,950 | 84,407 | Jun 25, 2021, 06:29 PM |
| Knowles Julius | Director | Jun 03, 2021 | Sale | $47.97 | 7,895 | 378,730 | 558,132 | Jun 03, 2021, 08:06 PM |
| Knowles Julius | Director | Jun 02, 2021 | Sale | $48.76 | 11,529 | 562,138 | 562,028 | Jun 03, 2021, 08:06 PM |
| Knowles Julius | Director | Jun 01, 2021 | Sale | $52.51 | 8,812 | 462,686 | 569,996 | Jun 03, 2021, 08:06 PM |
| Ordonez Claudia | Chief Medical Officer | May 11, 2021 | Option Exercise | $0.48 | 1,000 | 480 | 1,000 | May 13, 2021, 04:37 PM |
| Ordonez Claudia | Chief Medical Officer | May 11, 2021 | Sale | $50.15 | 1,000 | 50,150 | 0 | May 13, 2021, 04:37 PM |
| Lachey Jennifer | Chief Scientific Officer | May 13, 2021 | Option Exercise | $0.12 | 6,720 | 834 | 77,907 | May 13, 2021, 04:36 PM |
| Lachey Jennifer | Chief Scientific Officer | May 11, 2021 | Option Exercise | $0.30 | 2,650 | 795 | 73,837 | May 13, 2021, 04:36 PM |
| Lachey Jennifer | Chief Scientific Officer | May 11, 2021 | Sale | $50.00 | 2,650 | 132,500 | 71,187 | May 13, 2021, 04:36 PM |
| Ordonez Claudia | Chief Medical Officer | Apr 12, 2021 | Option Exercise | $0.48 | 1,000 | 480 | 1,000 | Apr 14, 2021, 04:46 PM |
| Ordonez Claudia | Chief Medical Officer | Apr 12, 2021 | Sale | $59.93 | 1,000 | 59,926 | 600 | Apr 14, 2021, 04:46 PM |
| Lachey Jennifer | Chief Scientific Officer | Apr 12, 2021 | Option Exercise | $0.30 | 5,300 | 1,590 | 76,487 | Apr 14, 2021, 04:43 PM |
| Lachey Jennifer | Chief Scientific Officer | Apr 12, 2021 | Sale | $60.00 | 5,300 | 318,026 | 75,489 | Apr 14, 2021, 04:43 PM |
| Knowles Julius | Director | Apr 05, 2021 | Sale | $60.07 | 27,151 | 1,630,832 | 622,909 | Apr 05, 2021, 09:11 PM |
| Knowles Julius | Director | Apr 01, 2021 | Sale | $58.89 | 11,202 | 659,704 | 626,197 | Apr 05, 2021, 09:11 PM |
| Lachey Jennifer | Chief Scientific Officer | Apr 01, 2021 | Option Exercise | $0.11 | 9,996 | 1,100 | 71,187 | Apr 02, 2021, 04:32 PM |
| Ordonez Claudia | Chief Medical Officer | Mar 11, 2021 | Option Exercise | $0.48 | 1,000 | 480 | 1,000 | Mar 15, 2021, 04:45 PM |
| Ordonez Claudia | Chief Medical Officer | Mar 11, 2021 | Sale | $64.56 | 1,000 | 64,556 | 605 | Mar 15, 2021, 04:45 PM |
| Lachey Jennifer | Chief Scientific Officer | Mar 11, 2021 | Option Exercise | $0.30 | 5,300 | 1,590 | 66,491 | Mar 15, 2021, 04:43 PM |
| Lachey Jennifer | Chief Scientific Officer | Mar 11, 2021 | Sale | $64.48 | 5,300 | 341,750 | 64,752 | Mar 15, 2021, 04:43 PM |
| Knowles Julius | Director | Mar 04, 2021 | Sale | $55.48 | 11,632 | 645,385 | 635,365 | Mar 05, 2021, 07:44 PM |
| Knowles Julius | Director | Mar 03, 2021 | Sale | $57.36 | 12,327 | 707,115 | 643,695 | Mar 05, 2021, 07:44 PM |
| Knowles Julius | Director | Mar 01, 2021 | Sale | $63.09 | 12,979 | 818,793 | 657,219 | Mar 03, 2021, 08:40 PM |
| Knowles Julius | Director | Mar 02, 2021 | Sale | $58.75 | 10,711 | 629,285 | 647,327 | Mar 03, 2021, 08:40 PM |
| Lachey Jennifer | Chief Scientific Officer | Feb 26, 2021 | Option Exercise | $0.11 | 33,200 | 3,652 | 61,191 | Mar 01, 2021, 04:54 PM |
| Knowles Julius | Director | Feb 18, 2021 | Sale | $63.11 | 2,944 | 185,785 | 660,379 | Feb 18, 2021, 06:46 PM |
| Knowles Julius | Director | Feb 17, 2021 | Sale | $61.05 | 16,061 | 980,588 | 669,685 | Feb 18, 2021, 06:46 PM |
| Knowles Julius | Director | Feb 16, 2021 | Sale | $59.89 | 9,612 | 575,671 | 675,481 | Feb 18, 2021, 06:46 PM |
| Knowles Julius | Director | Feb 12, 2021 | Sale | $61.53 | 7,468 | 459,495 | 679,390 | Feb 16, 2021, 05:50 PM |
| Knowles Julius | Director | Feb 11, 2021 | Sale | $64.82 | 11,561 | 749,441 | 687,251 | Feb 16, 2021, 05:50 PM |
| Ordonez Claudia | Chief Medical Officer | Feb 11, 2021 | Option Exercise | $0.48 | 1,000 | 480 | 1,000 | Feb 16, 2021, 05:49 PM |
| Ordonez Claudia | Chief Medical Officer | Feb 11, 2021 | Sale | $64.84 | 1,000 | 64,841 | 825 | Feb 16, 2021, 05:49 PM |
| Lachey Jennifer | Chief Scientific Officer | Feb 11, 2021 | Option Exercise | $0.30 | 5,300 | 1,590 | 33,291 | Feb 16, 2021, 05:47 PM |
| Lachey Jennifer | Chief Scientific Officer | Feb 11, 2021 | Sale | $64.91 | 5,300 | 344,017 | 32,844 | Feb 16, 2021, 05:47 PM |
| Nussbaum Ran | Director | Nov 17, 2020 | Buy | $50.00 | 60,000 | 3,000,000 | 2,288,151 | Nov 19, 2020, 04:40 PM |
| Kariv Tomer | Director | Nov 17, 2020 | Buy | $50.00 | 60,000 | 3,000,000 | 2,288,151 | Nov 19, 2020, 04:39 PM |
| Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Nov 17, 2020 | Buy | $50.00 | 60,000 | 3,000,000 | 2,288,151 | Nov 19, 2020, 04:38 PM |
| Arkin Bio Ventures Limited Partnership | 10% Owner | Apr 13, 2020 | Buy | $16.00 | 120,000 | 1,920,000 | 2,013,102 | Apr 13, 2020, 05:29 PM |
| Seehra Jasbir | Chief Executive Officer | Apr 13, 2020 | Buy | $16.00 | 20,000 | 320,000 | 243,856 | Apr 13, 2020, 05:19 PM |
| Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Apr 13, 2020 | Buy | $16.00 | 437,499 | 6,999,984 | 2,261,517 | Apr 13, 2020, 05:18 PM |
| ORBIMED ADVISORS LLC | Director | Apr 13, 2020 | Buy | $16.00 | 375,200 | 6,003,200 | 1,119,812 | Apr 13, 2020, 05:17 PM |
| Nussbaum Ran | Director | Apr 13, 2020 | Buy | $16.00 | 437,499 | 6,999,984 | 2,261,517 | Apr 13, 2020, 05:16 PM |
| Lazarus Alon | Director | Apr 13, 2020 | Buy | $16.00 | 120,000 | 1,920,000 | 2,013,102 | Apr 13, 2020, 05:15 PM |
| Kariv Tomer | Director | Apr 13, 2020 | Buy | $16.00 | 437,499 | 6,999,984 | 2,261,517 | Apr 13, 2020, 05:13 PM |
| GORDON CARL L | Director | Apr 13, 2020 | Buy | $16.00 | 375,200 | 6,003,200 | 1,119,812 | Apr 13, 2020, 05:12 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| GORDON CARL L | Director | 08/13/2024 | 11,002,500 |
| ORBIMED ADVISORS LLC | Director | 08/13/2024 | 11,002,500 |
| Regnante Keith | Chief Financial Officer | 11/04/2023 | 640,000 |
| Regnante Keith | Chief Financial Officer | 11/04/2023 | 1,811,600 |
| Regnante Keith | Chief Financial Officer | 06/09/2023 | 320,000 |
| Regnante Keith | Chief Financial Officer | 06/08/2023 | 320,000 |
| Regnante Keith | Chief Financial Officer | 06/08/2023 | 955,872 |
| Regnante Keith | Chief Financial Officer | 06/09/2023 | 908,367 |
| Seehra Jasbir | Chief Executive Officer | 04/08/2023 | 1,920 |
| Knowles Julius | Director | 04/13/2020 | 24,987 |
| Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | 11/29/2022 | 1 |
| Nussbaum Ran | Director | 11/29/2022 | 1 |
| Kariv Tomer | Director | 11/29/2022 | 1 |
| Lachey Jennifer | Chief Scientific Officer | 07/15/2022 | 13,810 |
| Lachey Jennifer | Chief Scientific Officer | 07/15/2022 | 1,381,020 |
| Lachey Jennifer | Chief Scientific Officer | 07/13/2022 | 575 |
| Lachey Jennifer | Chief Scientific Officer | 07/13/2022 | 57,480 |
| Lachey Jennifer | Chief Scientific Officer | 06/14/2022 | 2,820 |
| Seehra Jasbir | Chief Executive Officer | 06/09/2022 | 1,500 |
| Lachey Jennifer | Chief Scientific Officer | 05/11/2022 | 1,590 |
| Lachey Jennifer | Chief Scientific Officer | 05/11/2022 | 222,050 |
| Lachey Jennifer | Chief Scientific Officer | 04/11/2022 | 1,590 |
| Lachey Jennifer | Chief Scientific Officer | 04/11/2022 | 332,705 |
| Rovaldi Christopher | Chief Operating Officer | 04/06/2022 | 27,648 |
| Rovaldi Christopher | Chief Operating Officer | 04/06/2022 | 112,320 |
| Lachey Jennifer | Chief Scientific Officer | 04/04/2022 | 2,385 |
| Lachey Jennifer | Chief Scientific Officer | 04/04/2022 | 477,000 |
| Rovaldi Christopher | Chief Operating Officer | 04/01/2022 | 13,824 |
| Rovaldi Christopher | Chief Operating Officer | 04/01/2022 | 49,675 |
| Lachey Jennifer | Chief Scientific Officer | 03/11/2022 | 795 |
| Lachey Jennifer | Chief Scientific Officer | 03/11/2022 | 141,449 |
| Lachey Jennifer | Chief Scientific Officer | 02/11/2022 | 795 |
| Lachey Jennifer | Chief Scientific Officer | 02/11/2022 | 137,965 |
| Lachey Jennifer | Chief Scientific Officer | 01/11/2022 | 795 |
| Lachey Jennifer | Chief Scientific Officer | 01/11/2022 | 142,447 |
| Lachey Jennifer | Chief Scientific Officer | 01/05/2022 | 795 |
| Lachey Jennifer | Chief Scientific Officer | 01/05/2022 | 159,000 |
| Knowles Julius | Director | 01/05/2022 | 234,991 |
| Knowles Julius | Director | 01/04/2022 | 1,154,667 |
| Knowles Julius | Director | 01/03/2022 | 1,366,458 |
| Lachey Jennifer | Chief Scientific Officer | 12/13/2021 | 575 |
| Lachey Jennifer | Chief Scientific Officer | 12/15/2021 | 221 |
| Lachey Jennifer | Chief Scientific Officer | 12/15/2021 | 36,750 |
| Lachey Jennifer | Chief Scientific Officer | 12/13/2021 | 96,808 |
| Knowles Julius | Director | 12/02/2021 | 1,357,381 |
| Knowles Julius | Director | 12/01/2021 | 1,219,994 |
| Lachey Jennifer | Chief Scientific Officer | 11/10/2021 | 4,770 |
| Lachey Jennifer | Chief Scientific Officer | 11/11/2021 | 1,590 |
| Lachey Jennifer | Chief Scientific Officer | 11/10/2021 | 954,000 |
| Lachey Jennifer | Chief Scientific Officer | 11/11/2021 | 316,058 |
| Lachey Jennifer | Chief Scientific Officer | 11/04/2021 | 3,180 |
| Lachey Jennifer | Chief Scientific Officer | 11/04/2021 | 530,000 |
| Knowles Julius | Director | 11/03/2021 | 669,780 |
| Knowles Julius | Director | 11/02/2021 | 334,149 |
| Knowles Julius | Director | 11/01/2021 | 1,003,201 |
| Knowles Julius | Director | 10/20/2021 | 156,095 |
| Knowles Julius | Director | 10/19/2021 | 172,346 |
| Knowles Julius | Director | 10/15/2021 | 321,052 |
| Knowles Julius | Director | 10/14/2021 | 175,890 |
| Knowles Julius | Director | 10/18/2021 | 519,711 |
| Knowles Julius | Director | 10/05/2021 | 104,759 |
| Knowles Julius | Director | 10/04/2021 | 150,065 |
| Knowles Julius | Director | 10/01/2021 | 253,932 |
| Knowles Julius | Director | 09/27/2021 | 3,924,003 |
| Lachey Jennifer | Chief Scientific Officer | 08/17/2021 | 388 |
| Knowles Julius | Director | 07/02/2021 | 984,565 |
| Knowles Julius | Director | 07/01/2021 | 983,787 |
| Lachey Jennifer | Chief Scientific Officer | 06/24/2021 | 1,950 |
| Knowles Julius | Director | 06/03/2021 | 378,730 |
| Knowles Julius | Director | 06/02/2021 | 562,138 |
| Knowles Julius | Director | 06/01/2021 | 462,686 |
| Ordonez Claudia | Chief Medical Officer | 05/11/2021 | 480 |
| Ordonez Claudia | Chief Medical Officer | 05/11/2021 | 50,150 |
| Lachey Jennifer | Chief Scientific Officer | 05/13/2021 | 834 |
| Lachey Jennifer | Chief Scientific Officer | 05/11/2021 | 795 |
| Lachey Jennifer | Chief Scientific Officer | 05/11/2021 | 132,500 |
| Ordonez Claudia | Chief Medical Officer | 04/12/2021 | 480 |
| Ordonez Claudia | Chief Medical Officer | 04/12/2021 | 59,926 |
| Lachey Jennifer | Chief Scientific Officer | 04/12/2021 | 1,590 |
| Lachey Jennifer | Chief Scientific Officer | 04/12/2021 | 318,026 |
| Knowles Julius | Director | 04/05/2021 | 1,630,832 |
| Knowles Julius | Director | 04/01/2021 | 659,704 |
| Lachey Jennifer | Chief Scientific Officer | 04/01/2021 | 1,100 |
| Ordonez Claudia | Chief Medical Officer | 03/11/2021 | 480 |
| Ordonez Claudia | Chief Medical Officer | 03/11/2021 | 64,556 |
| Lachey Jennifer | Chief Scientific Officer | 03/11/2021 | 1,590 |
| Lachey Jennifer | Chief Scientific Officer | 03/11/2021 | 341,750 |
| Knowles Julius | Director | 03/04/2021 | 645,385 |
| Knowles Julius | Director | 03/03/2021 | 707,115 |
| Knowles Julius | Director | 03/01/2021 | 818,793 |
| Knowles Julius | Director | 03/02/2021 | 629,285 |
| Lachey Jennifer | Chief Scientific Officer | 02/26/2021 | 3,652 |
| Knowles Julius | Director | 02/18/2021 | 185,785 |
| Knowles Julius | Director | 02/17/2021 | 980,588 |
| Knowles Julius | Director | 02/16/2021 | 575,671 |
| Knowles Julius | Director | 02/12/2021 | 459,495 |
| Knowles Julius | Director | 02/11/2021 | 749,441 |
| Ordonez Claudia | Chief Medical Officer | 02/11/2021 | 480 |
| Ordonez Claudia | Chief Medical Officer | 02/11/2021 | 64,841 |
| Lachey Jennifer | Chief Scientific Officer | 02/11/2021 | 1,590 |
| Lachey Jennifer | Chief Scientific Officer | 02/11/2021 | 344,017 |
| Nussbaum Ran | Director | 11/17/2020 | 3,000,000 |
| Kariv Tomer | Director | 11/17/2020 | 3,000,000 |
| Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | 11/17/2020 | 3,000,000 |
| Arkin Bio Ventures Limited Partnership | 10% Owner | 04/13/2020 | 1,920,000 |
| Seehra Jasbir | Chief Executive Officer | 04/13/2020 | 320,000 |
| Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | 04/13/2020 | 6,999,984 |
| ORBIMED ADVISORS LLC | Director | 04/13/2020 | 6,003,200 |
| Nussbaum Ran | Director | 04/13/2020 | 6,999,984 |
| Lazarus Alon | Director | 04/13/2020 | 1,920,000 |
| Kariv Tomer | Director | 04/13/2020 | 6,999,984 |
| GORDON CARL L | Director | 04/13/2020 | 6,003,200 |
Load More Insider Transactions
FUNDS WITH A POSITION IN KEROS THERAPEUTICS, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 2,513,244 | 0.0026% | 16.03% | Other |
| ORBIMED ADVISORS LLC | 899,212 | 0.78% | -29.13% | Other |
| HOLOCENE ADVISORS, LP | 688,326 | 0.13% | 7.89% | Growth At A Reasonable Price |
| GEODE CAPITAL MANAGEMENT, LLC | 679,580 | 0.00273% | 14.05% | Other |
| CANDRIAM S.C.A. | 441,855 | 0.12% | -32.23% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 230,000 | 0.02% | 21.05% | Other |
| D. E. SHAW & CO., INC. | 175,695 | 0.00751% | 830.88% | Other |
| WCM INVESTMENT MANAGEMENT, LLC | 116,544 | 0.01% | -0.42% | Growth At A Reasonable Price |
| BALYASNY ASSET MANAGEMENT L.P. | 88,636 | 0.00709% | 247.43% | Event Driven |
| PLATINUM INVESTMENT MANAGEMENT LTD | 20,293 | 0.04% | -41.54% | Growth At A Reasonable Price, Value |
| ALPS ADVISORS INC | 28,144 | 0.00883% | 10.9% | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 22,453 | 0.06% | 31.67% | Value |
| TUDOR INVESTMENT CORP ET AL | 10,357 | 0.00242% | -39.09% | Event Driven, Other |
| RENAISSANCE TECHNOLOGIES LLC | 14,300 | 0.00111% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR KEROS THERAPEUTICS, INC.
STOCK BUYBACKS FOR KEROS THERAPEUTICS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
18.42%
1Q
09/30/2023
20.28%
2Q
06/30/2023
20.55%
3Q
03/31/2023
25.79%
4Q
12/31/2022
30.48%
5Q
09/30/2022
39.67%
6Q
06/30/2022
48.36%
7Q
03/31/2022
48.73%
8Q
12/31/2021
52.26%
9Q
09/30/2021
52.75%
10Q
06/30/2021
53.12%
11Q
03/31/2021
53.62%
12Q
09/30/2020
76.87%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR KEROS THERAPEUTICS, INC.
LOADING...